Eczema Therapeutics Market is driven by Rising Prevalence of Atopic Dermatitis
The eczema therapeutics market offers a wide range of products like corticosteroids, calcineurin inhibitors, immunosuppressants, biologics and others used for treating various symptoms of eczema in patients. Eczema therapies are predominantly used in the treatment of atopic dermatitis which is the most common form of eczema. These products provide relief from itching, redness and inflammation associated with eczema.
The Global eczema therapeutics market is estimated to be valued at US$ 21973.78 Bn in 2024 and is expected to exhibit a CAGR of
Like
Comment
Share
